SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bio Technology General - BTGC -- Ignore unavailable to you. Want to Upgrade?


To: tktrimbath who wrote (2006)6/5/2000 8:36:00 PM
From: Jim Oravetz  Read Replies (1) | Respond to of 2028
 
In general there has been a rotation out of big pharma to biotech's. That could explain a some of the volume and uptick. The company was pretty beaten down near the $10/sh level. It has profits, although not all that great. A part of thier pile of money is going into a new production plant ($30M). They are on the verge of selling HGH in the US - that is most likely the attractivness.

Jim